Pneumothorax during Pazopanib Treatment in Patients with Soft-Tissue Sarcoma: Two Case Reports and a Review of the Literature

Pneumothorax during Pazopanib Treatment in Patients with Soft-Tissue Sarcoma: Two Case Reports and a Review of the Literature

Pazopanib, a multitargeting tyrosine kinase inhibitor, has single-agent activity in patients with advanced soft-tissue sarcoma. Herein, we describe 2 cases of pneumothorax that occurred during pazopanib treatment in patients with soft-tissue sarcoma. These 2 patients had multiple lung metastases. Ac...

Full description

Bibliographic Details
Main Authors: Yoshiro Nakahara, Tomoya Fukui, Ken Katono, Yuuki Nishizawa, Yusuke Okuma, Masachika Ikegami, Jiichiro Sasaki, Noriyuki Masuda
Format: Article
Language:English
Published: Karger Publishers 2017-04-01
Series:Case Reports in Oncology
Subjects:
Pneumothorax
Soft-tissue sarcoma
Pazopanib
Online Access:http://www.karger.com/Article/FullText/463380

Internet

http://www.karger.com/Article/FullText/463380

Similar Items